Company
ITB-Med LLC
ITB-Med LLC has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Siplizumab | Phase 2 | Renal Transplant Failure and Rejection |
Latest
No recent events.
Follow ITB-Med LLC on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.